Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Foundation Medicine (FMI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck

Foundation Medicine, Inc. (NASDAQ:FMI) today announced a collaboration with Merck, known as MSD outside the United States and Canada, to develop companion diagnostic tests for use...

FMI : 90.00 (+4.90%)
MRK : 59.13 (-0.07%)
Freenome is Conducting the First Clinical Validation Study of an AI-Genomics Blood Test - and Ramps Up Commercial Hiring

Freenome, the AI genomics company seeking to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases, announced two major milestones on its...

FMI : 90.00 (+4.90%)
Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights

Foundation Medicine (NASDAQ:FMI) today reported financial and operational results for the first quarter ended March 31, 2018. Highlights for the quarter included:

FMI : 90.00 (+4.90%)
Foundation Medicine Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer

Foundation Medicine, Inc. (NASDAQ:FMI) today announced a comprehensive gene expression profiling (GEP) program to support precision oncology clinical research and development. This...

FMI : 90.00 (+4.90%)
Foundation Medicine's New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the U.S. Food and Drug Administration (FDA) granted a Breakthrough Device designation (formerly Expedited Access Pathway...

FMI : 90.00 (+4.90%)
How BTCY Could Look a Lot Like SRPT in a Year's Time

- Sarepta Therapeutics (SRTP) faced headwinds as they brought their new drug Exondys 51 to the market in the last two years, but the company and its stock have done very well with great execution on the...

FMI : 90.00 (+4.90%)
SRPT : 89.99 (+1.16%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ARDX , SGMO , FMI , INSY , KPTI )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

SGMO : 16.30 (+1.87%)
FMI : 90.00 (+4.90%)
ARDX : 3.80 (-2.56%)
Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's first quarter ended March 31, 2018 will be released on Wednesday, May 2, 2018. The management...

FMI : 90.00 (+4.90%)
Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies

Foundation Medicine, Inc. (NASDAQ:FMI) today announced the presentation of new findings at the American Association for Cancer Research (AACR) Annual Meeting. The data supports the...

FMI : 90.00 (+4.90%)
Foundation Medic Rises 6.78% on Heavy Volume: Watch For Potential Pullback

Foundation Medic (NASDAQ:FMI) traded in a range yesterday that spanned from a low of $72.55 to a high of $76.80. Yesterday, the shares gained 6.8%, which took the trading range above the 3-day high of...

FMI : 90.00 (+4.90%)
Cancer Treatment Centers of America and Foundation Medicine Launch Joint Educational Campaign to Raise Consumer Awareness of Precision Medicine Approaches in Cancer Care

Cancer Treatment Centers of America® (CTCA), a national network of comprehensive cancer care hospitals and outpatient care centers, and Foundation Medicine, a leading molecular insights company that recently...

FMI : 90.00 (+4.90%)
Notable Wednesday Option Activity: FMI, TRUP, THO

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Foundation Medicine Inc , where a total of 2,913 contracts have traded so far, representing...

FMI : 90.00 (+4.90%)
SmarTrend Watching for Potential Rebound in Shares of Foundation Medic After 6.90% Loss

Foundation Medic (NASDAQ:FMI) traded in a range yesterday that spanned from a low of $66.75 to a high of $73.55. Yesterday, the shares fell 6.9%, which took the trading range below the 3-day low of $70.95...

FMI : 90.00 (+4.90%)
First Week of FMI November 16th Options Trading

Investors in Foundation Medicine Inc saw new options begin trading this week, for the November 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay,...

FMI : 90.00 (+4.90%)
Foundation Medicine Announces Commercial Availability of FoundationOne CDx(TM), the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagnostics

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that FoundationOne CDx(TM), the first U.S. Food and Drug Administration (FDA) approved comprehensive genomic profiling (CGP)...

FMI : 90.00 (+4.90%)
Research Report Identifies Beazer Homes, Extra Space Storage, Foundation Medicine, Kennametal, Midstates Petroleum, and Corporate Office Properties Trust with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Beazer Homes USA, Inc. (NYSE:BZH),...

BZH : 15.32 (+0.39%)
FMI : 90.00 (+4.90%)
KMT : 39.35 (+0.54%)
MPO : 13.12 (-2.24%)
OFC : 27.50 (-0.54%)
EXR : 95.10 (+1.45%)
Blog Exposure - Foundation Medicine Collaborated with Chugai for Commercialization of FoundationOne CDx(TM) in Japan

Stock Monitor: Miragen Therapeutics Post Earnings Reporting

FMI : 90.00 (+4.90%)
CHGCF : 53.8700 (+3.64%)
MGEN : 6.86 (-4.99%)
Foundation Medicine Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDx(TM) Across All Solid Tumors

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the Centers for Medicare & Medicaid Services (CMS) issued a final National Coverage Determination (NCD) for patients who...

FMI : 90.00 (+4.90%)
Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx(TM) in Japan

Foundation Medicine, Inc. (NASDAQ:FMI) today announced that Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519), one of Japan's leading research-based pharmaceutical companies and a member...

FMI : 90.00 (+4.90%)
Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit

Foundation Medicine, Inc. (NASDAQ:FMI) and Guardant Health, Inc. announced an agreement to settle false advertising challenges that the companies had filed against each other under...

FMI : 90.00 (+4.90%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar